[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE7501967L - - Google Patents

Info

Publication number
SE7501967L
SE7501967L SE7501967A SE7501967A SE7501967L SE 7501967 L SE7501967 L SE 7501967L SE 7501967 A SE7501967 A SE 7501967A SE 7501967 A SE7501967 A SE 7501967A SE 7501967 L SE7501967 L SE 7501967L
Authority
SE
Sweden
Prior art keywords
contg
soluble
capsule
compsns
overdosing
Prior art date
Application number
SE7501967A
Other languages
Unknown language ( )
Other versions
SE426549B (en
Inventor
E A Holstius
R M Cresswell
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE7501967L publication Critical patent/SE7501967L/
Publication of SE426549B publication Critical patent/SE426549B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compsns. contg. digoxin (I) soln. in a soluble capsule coating are new. The capsule is pref. soluble in the upper part of the mammalian gastro-intestinal tract, and is suitably of soft gelatin contg. \-1 of plasticisers, preservatives dyes and opacifiers, Dosage is esp. 0.05-0.4 mg (I) per unit. (I) is used in treatment of cardiac insufficiency. (I) is taken up more rapidly and uniformly than when administered by tablets, so the risk of overdosing is reduced. The dose required is only 80% of that needed in tablet form.
SE7501967A 1974-02-22 1975-02-21 PREPARING ORAL ADMINISTRATIVE PHARMACEUTICAL PREPARATION CONTAINING DIGOXIN SE426549B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44496174A 1974-02-22 1974-02-22
US45300074A 1974-03-19 1974-03-19

Publications (2)

Publication Number Publication Date
SE7501967L true SE7501967L (en) 1975-08-25
SE426549B SE426549B (en) 1983-01-31

Family

ID=27034126

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7501967A SE426549B (en) 1974-02-22 1975-02-21 PREPARING ORAL ADMINISTRATIVE PHARMACEUTICAL PREPARATION CONTAINING DIGOXIN

Country Status (14)

Country Link
JP (1) JPS50126822A (en)
AU (2) AU501549B2 (en)
CA (1) CA1096307A (en)
DE (1) DE2507635A1 (en)
ES (1) ES434971A1 (en)
FI (1) FI750489A (en)
FR (1) FR2261752B1 (en)
GB (1) GB1506016A (en)
IE (1) IE41620B1 (en)
IL (1) IL46682A (en)
IT (1) IT1233251B (en)
LU (1) LU71894A1 (en)
NL (1) NL7502121A (en)
SE (1) SE426549B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508770A (en) * 1974-04-01 1978-04-26 Scherer Ltd R Pharmaceutical compositions
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
DE2805165A1 (en) * 1977-02-09 1978-08-10 Christiaens Sa A MEDICINAL PRODUCT CONTAINING GITOXIN AND THE METHOD OF MANUFACTURING IT
IT1158722B (en) * 1977-07-08 1987-02-25 Simes PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SLEEP TURBES
JPS5625428U (en) * 1979-08-03 1981-03-09
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
SE8203953D0 (en) * 1982-06-24 1982-06-24 Astra Laekemedel Ab PHARMACEUTICAL MIXTURE
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
DE3445237C1 (en) * 1984-12-12 1986-06-05 R.P. Scherer GmbH, 6930 Eberbach Soft gelatin capsules and process for their manufacture
DE3529694A1 (en) * 1985-08-20 1987-02-26 Scherer Gmbh R P GELATINE CAPSULES AND METHOD FOR THEIR PRODUCTION

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1481411A (en) * 1973-07-20 1977-07-27 Scherer Ltd R Pharmaceutical compositions

Also Published As

Publication number Publication date
FI750489A (en) 1975-08-23
IT8349395A0 (en) 1983-11-28
FR2261752B1 (en) 1978-07-21
IL46682A (en) 1979-07-25
AU501549B2 (en) 1979-06-21
SE426549B (en) 1983-01-31
FR2261752A1 (en) 1975-09-19
CA1096307A (en) 1981-02-24
AU520082B2 (en) 1982-01-14
AU7844075A (en) 1976-08-26
IL46682A0 (en) 1975-04-25
IE41620B1 (en) 1980-02-13
GB1506016A (en) 1978-04-05
ES434971A1 (en) 1977-05-16
IT1233251B (en) 1992-03-24
JPS50126822A (en) 1975-10-06
LU71894A1 (en) 1975-12-09
NL7502121A (en) 1975-08-26
DE2507635C2 (en) 1991-07-25
IE41620L (en) 1975-08-22
DE2507635A1 (en) 1975-08-28

Similar Documents

Publication Publication Date Title
ES442579A1 (en) Effervescent enteric coated L-dopa formulation and method of using the same
ES303909A1 (en) A procedure for coating a pharmaceutical composition. (Machine-translation by Google Translate, not legally binding)
ATE67677T1 (en) MEDICATIONS FOR ORAL ADMINISTRATION CONTAINING 10 TO 240 MG OF DIHYDROPYRIDINE IN A SINGLE DOSE.
JPS5587716A (en) Cardiotonic glycoside containing medicine
JPS5225013A (en) Insulin pharmaceutical for nasal administration
YU48583B (en) Process for preparation of the formulation in the form of pill for oral dosage
IT1233251B (en) Digoxin solns in capsule form
ES443910A1 (en) Benzoic acids, their derivatives and process for preparing them
ZA795530B (en) Pharmaceutical tablet for oral administration and process for its manufacture
CA982478A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
GB1459675A (en) Method for the prevention of conception
IE42950L (en) X-ray contrast preparations
Kramer Methotrexate and radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, oropharynx, supraglottic larynx, and hypopharynx.(Preliminary report of a controlled clinical trial of the Radiation Therapy Oncology Group)
CA2051369A1 (en) Thyroid hormone cardiac treatment
MY100780A (en) Azumolene dosage form.
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
ES447712A1 (en) Pharmaceutical suspension for opaqing empty gelatin capsules
FR2077913A1 (en) Tablets contg gelatine capsules - for administration of liquid medicaments
GB1429977A (en) Diuretic composition
FR2260995A1 (en) Benzimidazole-contg. medicaments - for treating non-malignant gastroduodenal disorders, esp. ulcers and hypersecretion
GB1173615A (en) Calcium Succinate
AU474224B2 (en) Copolymers of vinyl ethers and cyclic polyenes containing a system of conjugated double bonds and process forthe preparation thereof
GB1354643A (en) Pharmaceutical coating composition
JPS5569510A (en) Carcinostatic agent
JPS62123111A (en) Non-absorbable gastrointestinal drug supplied in from of gastric-soluble and gastric-resistant crude drug and curing two levels of digestive tract

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7501967-9

Effective date: 19910911

Format of ref document f/p: F